SPO Global (SPO Global) FCF Margin % : 16.54% (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is SPO Global FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. SPO Global's Free Cash Flow for the three months ended in Sep. 2023 was $0.77 Mil. SPO Global's Revenue for the three months ended in Sep. 2023 was $4.66 Mil. Therefore, SPO Global's FCF Margin % for the quarter that ended in Sep. 2023 was 16.54%.

As of today, SPO Global's current FCF Yield % is 62.81%.

The historical rank and industry rank for SPO Global's FCF Margin % or its related term are showing as below:

SPOM' s FCF Margin % Range Over the Past 10 Years
Min: -1810 Med: -106.33 Max: 16.54
Current: 16.54

During the past 13 years, the highest FCF Margin % of SPO Global was 16.54%. The lowest was -1810.00%. And the median was -106.33%.

SPOM's FCF Margin % is ranked better than
87.43% of 517 companies
in the Conglomerates industry
Industry Median: 2.39 vs SPOM: 16.54

SPO Global FCF Margin % Historical Data

The historical data trend for SPO Global's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SPO Global FCF Margin % Chart

SPO Global Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

FCF Margin %

Get a 7-Day Free Trial

-106.33

-54.50

-191.11

1.99

-222.61

SPO Global Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep22	Sep23
FCF Margin %	Get a 7-Day Free Trial															-321.05	-15.56	8.39	-	16.54

Competitive Comparison of SPO Global's FCF Margin %

For the Conglomerates subindustry, SPO Global's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SPO Global's FCF Margin % Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, SPO Global's FCF Margin % distribution charts can be found below:

* The bar in red indicates where SPO Global's FCF Margin % falls into.

SPO Global FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

SPO Global's FCF Margin for the fiscal year that ended in Dec. 2016 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2016 )	/	Revenue (A: Dec. 2016 )
	=	-0.256	/	0.115
	=	-222.61 %

SPO Global's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0.77	/	4.655
	=	16.54 %

SPO Global FCF Margin % Related Terms

Thank you for viewing the detailed overview of SPO Global's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

SPO Global (SPO Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634

Website

http://www.gerpanghealthcare.com

SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.

Executives

Jeffrey Louis Feuer	officer: Chief Financial Officer	21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan	officer: Chief Operating Officer	21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold	director, officer: Chief Executive Officer	C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun	director	SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman	director	183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi	10 percent owner, officer: Chief Technology Officer	C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367